Reuters logo
BRIEF-Cosmo Pharmaceuticals H1 profit after taxes up 209.2 pct to EUR 237.5 mln
2015年7月30日 / 凌晨5点23分 / 2 年前

BRIEF-Cosmo Pharmaceuticals H1 profit after taxes up 209.2 pct to EUR 237.5 mln

July 30 (Reuters) - Cosmo Pharmaceuticals SA :

* H1 profit after taxes increased by 209.2 pct to 237.5 million euros ($260.59 million)

* H1 revenues declined by 51.3 pct to 20 million euros

* H1 net operating expenses increased by 64.3 pct to 43.5 million euros

* For second half of 2015 management foresees revenues from Uceris to return to expected trends

* Profit before tax is expected at around 242 million euros for entire year

* From a clinical development perspective management is looking forward to end of phase III clinical trial of Methylene Blue MMX and successful completion of regulatory process for SIC 8000 Source text for Eikon: Further company coverage: ($1 = 0.9114 euros) (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below